Search for Clinical Trial Results

Sponsored By

Lymphangiomyoma - 25 Studies Found

Status Study
Completed Study Name: Effect of Fasting on the Size of Abdominal Lymphatic Tumors in Women
Condition:
  • Lymphangioleiomyomas
  • Tuberous Sclerosis
  • Lymphangioleiomyomatosis
  • Lymphangiomyomas
  • Drug: Imatinib Mesylate 400Mg Capsule

Recruiting Study Name: A Study of Nintedanib for LymphAngioleioMyomatosis (LAM)
Condition: Lymphangioleiomyomatosis
Date: 2016-10-07
Interventions: Drug: Nintedanib Other Name: OFEV
Recruiting Study Name: Safety and Efficacy of Saracatinib In Subjects With Lymphangioleiomyomatosis
Condition: Pulmonary Lymphangioleiomyomatosis
Date: 2016-03-31
Interventions: Drug: saracatinib Subjects will receive enough tablets for 90 days +/- 14 days at each visit. Subject wi
Recruiting Study Name: COLA: A Pilot Clinical Trial of COX-2 Inhibition in LAM and TSC
Condition: Lymphangioleiomyomatosis (LAM)
Date: 2015-06-25
Interventions: Drug: Celecoxib We will perform a pilot clinical trial to investigate the safety and tolerability of cel
Recruiting Study Name: Safety and Durability of Sirolimus for Treatment of LAM
Condition: Lymphangioleiomyomatosis
Date: 2015-03-04
Interventions:
  • Drug: Sirolimus Sirolimus trea
Completed Study Name: The Tolerability of Saracatinib in Subjects With Lymphangioleiomyomatosis (LAM) (SLAM-1)
Condition: Pulmonary Lymphangioleiomyomatosis
Date: 2014-04-15
Interventions: Drug: Saracatinib Saracatinib is escalated as follows: Three dose levels will be administered for 1 mont
Completed Study Name: Pulmonary Rehabilitation in Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Date: 2013-12-04
Interventions: Other: Pulmonary Rehabilitation
Recruiting Study Name: Nebulized or Inhaled Albuterol for Lymphangioleiomyomatosis
Condition: Lymphangioleiomyomatosis
Date: 2013-02-23
Interventions:
  • Drug: albuterol inhaler
  • Procedure: PFT
Next >>>